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SUMMARY
BAF complexes are composed of different subunits
with varying functional and developmental roles,
although many subunits have not been examined
in depth. Here we show that the Baf45 subunit Dpf2
maintains pluripotency and ESC differentiation po-
tential. Dpf2 co-occupies enhancers with Oct4, Sox2,
p300, and the BAF subunit Brg1, and deleting Dpf2
perturbs ESC self-renewal, induces repression of
Tbx3, and impairs mesendodermal differentiation
withoutdramaticallyalteringBrg1 localization.Mesen-
dodermal differentiation can be rescued by restoring
Tbx3 expression, whose distal enhancer is positively
regulated by Dpf2-dependent H3K27ac maintenance
and recruitment of pluripotency TFs and Brg1. In
contrast, the PRC2 subunit Eed binds an intragenic
Tbx3 enhancer to oppose Dpf2-dependent Tbx3
expression and mesendodermal differentiation. The
PRC2 subunit Ezh2 likewise opposes Dpf2-depen-
dent differentiation through a distinct mechanism
involving Nanog repression. Together, these findings
delineate distinct mechanistic roles for specific BAF
and PRC2 subunits during ESC differentiation.
INTRODUCTION
Embryonic stem cells (ESCs) are capable of self-renewal and dif-
ferentiation into all cell types of the body, which is conferred by
the coordination of key factors, including transcription factors
(TFs), polycomb complexes, microRNAs, and histone modifiers
(Tee and Reinberg, 2014; Li and Belmonte, 2017). Such factors
also include ATP-dependent chromatin remodeling complexes
that hydrolyze ATP to change the conformation of chromatin,
thereby modulating the access of TFs to chromosomal DNA (Ka-
doch and Crabtree, 2015). The mammalian switch/sucrose non-
fermentable (SWI-SNF) complex, also called the BAF (Brg or
Brahma-associated factors) complex, represents one subfamily
of the ATP-dependent chromatin remodeling superfamily and
forms polymorphic assemblies of up to 15 subunits with different
functional specificity based on subunit composition (Kadoch and
Crabtree, 2015). BAF complexes have been shown to be essen-
tial for mammalian pre- to post-implantation development (Ho
andCrabtree, 2010; Panamarova et al., 2016),and play important
roles in controlling the self-renewal and pluripotency of ESCs (Ho
and Crabtree, 2010). However, the function of only a small num-
ber of BAF complex subunits has been studied in ESCs and in
the early embryo, and how BAF complexes mechanistically con-
trol cell fate decisions is not well understood.
The BAF45 subunit is encoded by a family of four genes
(BAF45a, BAF45b, BAF45c, and BAF45d) that have different
expression patterns (Kadoch and Crabtree, 2015). These pro-
teins contain two plant homeodomain (PHD) fingers that may
target the BAF complex to genomic loci bearing specific histone
marks (Kadoch and Crabtree, 2015). In the mouse, BAF45a is
essential for the maintenance of hematopoietic stem cells (Kras-
teva et al., 2017) and for the self-renewal of neural progenitors
and is replaced by BAF45b/c as neural progenitors differentiate
(Kadoch and Crabtree, 2015), whereas BAF45c is critical for
heart and muscle development (Lange et al., 2008). BAF45d,
also called Dpf2, is the only ubiquitously expressed BAF45
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subunit (Mertsalov et al., 2000) and, so far, has been implicated
in the programmed cell death response after deprivation of inter-
leukin-3 from myeloid cells (Gabig et al., 1994). However, the
biochemical interaction of DPF2 with pluripotency TFs in ESCs
(Pardo et al., 2010; van den Berg et al., 2010) suggests a function
of this BAF subunit in pluripotent cells, which has not been exam-
ined to date.
Our study shows that deletion of Dpf2 in mouse ESCs
decreased their self-renewal ability and dramatically impaired
their differentiation into mesoderm and endoderm while promot-
ing neural ectoderm differentiation. The differentiation defect to
meso-endoderm could be rescued by restoring Tbx3 levels
in Dpf2/ ESCs. We also found that the PRC2 complex sub-
unit Eed oppositely regulates meso-endoderm differentiation
compared with Dpf2, also by regulating Tbx3 expression. Mech-
anistically, Dpf2 and Eed act on two different Tbx3-controlling
enhancers. We further demonstrate that Ezh2, another PRC2
subunit, also regulates meso-endoderm differentiation as
opposed to Dpf2 but through a distinct mechanism that involves
Nanog suppression. Thus, our work uncovers complex mecha-
nisms by which PRC2 subunits and the BAF subunitDpf2 control
differentiation of ESCs.
RESULTS
Dpf2 Loss Affects ESC Self-Renewal and Leads to
Increased Apoptosis and Cell-Cycle Defects
Given the previously described biochemical interaction of DPF2
with OCT4 in mouse ESCs (Pardo et al., 2010; van den Berg
et al., 2010) and the prominent role of OCT4 as a member of
the core pluripotency network (Li and Belmonte, 2017), we
set out to study the role of Dpf2 in ESCs. Specifically, we gener-
ated a conditional of Dpf2 allele in ESCs by adding LoxP sites
around exon 4 (Figure S1A). 4-Hydroxytamoxifen (4-OHT) treat-
ment of Dpf2 fl/fl ESCs resulted in an out-of-frame mutation
yielding a complete Dpf2 knockout (KO) at the protein level
(Figure S1B).
We first tested the role of Dpf2 in ESC self-renewal. Absence
of Dpf2 expression led to a decrease in colony formation (Fig-
ure 1A), suggesting an impairment of self-renewal ability. The
lower colony number arising from Dpf2/ cells coincided with
a small increase in apoptosis under feeder-free conditions in
Lif and serum-containing medium because Dpf2 fl/fl cells were
more prone to apoptosis (27% cell death) than wild-type
(WT) ESCs (14%)when treatedwith 4-OHT for 96 hr (Figure 1B).
More significant cell death was also observed for Dpf2/ ESCs
cultured in N2B27 medium with BMP4 and leukemia inhibitory
factor (Lif) (Figure S1C). Additionally, Dpf2 deletion resulted in
an 10% increase in cells in the G2-M cell cycle phases,
whereas17% fewer cells were present in S phase (Figure S1D).
In addition to the decreased ability to form colonies, alkaline
phosphatase (AP) staining revealed a decrease in homoge-
neously stained, undifferentiated colonies in Dpf2/ ESCs (Fig-
ure 1C). We conclude that increased apoptosis, changes in the
cell cycle, and an impaired ability to form colonies are conse-
quences of Dpf2 deletion in ESCs.
Dpf2 deletion had no effect on core pluripotency regulators
such as Oct4 and Sox2 both at the transcript and protein levels
(Figures 1D and 1E), indicating that the self-renewal defects
observed in Dpf2/ ESCs were not associated with precocious
differentiation. However,Nanog expression decreased slightly at
both the transcript and protein levels, and the expression of
other pluripotency regulators, including Tbx3, Klf4, and Klf5,
was significantly decreased (Figures 1D and 1E). Previous re-
ports have demonstrated the importance of Tbx3 for the mainte-
nance of ESC self-renewal (Ivanova et al., 2006) and the ability of
Klfs to support ESC self-renewal (Hall et al., 2009), suggesting
that the action of DPF2 on these genes could be critical for
ESC self-renewal.
To explore the molecular mechanisms of Dpf2 in ESCs, we
fused an affinity purification (FTAP) tag (Bode et al., 2016) to
the C terminus of one endogenous Dpf2 allele in ESCs (Figures
S1E and S1F) and, after cross-linking of cells with formalde-
hyde to stabilize transient interactions, performed affinity purifi-
cation of DPF2-containing protein complexes, followed by
mass spectrometry (Figure 1F), and confirmed the results
with immunoprecipitation followed by western blotting. We
identified 80 high-confidence DPF2 interaction partners (Table
S1; Figure 1G), including several components of the BAF com-
plex (BRG1 [SMARCA4], ARID1A, BAF155 [SMARCC1], BAF57
[SMARCE1], and BAF170 [SMARCC2]) (Figure S1G), corrobo-
rating that DPF2 is a subunit of the BAF complex in ESCs.
Gene ontology (GO) analysis of the DPF2 interactome revealed
a significant association with proteins that exhibit chromatin-
regulatory functions, including the nucleosome remodeling de-
acetylase (NuRD) complex (Figure 1H). In agreement with the
cell cycle defect in Dpf2/ ESCs, DPF2 associated with pro-
teins implicated in regulation of the cell cycle and DNA replica-
tion initiation (Figures 1G and 1H), including most subunits of
the mini chromosome maintenance (MCM) complex, which
controls DNA replication (Forsburg, 2004), suggesting that
Dpf2 (and the BAF complex) may affect the ESC cell cycle by
Figure 1. Loss of Dpf2 Affects ESC Self-Renewal and Leads to Increased Apoptosis and Cell-Cycle Defects
(A) Quantification of a colony-formation assay for WT, Dpf2fl/fl, and Dpf2/ mouse ESCs. Given is the mean of three replicates and the SD. ***p < 0.001.
(B) Representative fluorescence-activated cell sorting (FACS) plots of Annexin V and 7-aminoactinomycin D (7-AAD) levels in Dpf2fl/fl and WT control ESCs.
Percentages of cells with different apoptosis marker levels are indicated in brackets.
(C) Alkaline phosphatase (AP) staining assay for Dpf2fl/fl and Dpf2/ ESCs. Colonies were scored as undifferentiated (undiff), mixed, and differentiated (diff). The
mean and SD of three replicates is displayed. *p < 0.05, **p < 0.01.
(D) Transcript levels of pluripotency-associated genes in Dpf2fl/fl and Dpf2/ ESCs based on qPCR.
(E) Western blot for OCT4, SOX2, NANOG, and TBX3 protein levels in Dpf2fl/fl and Dpf2/ ESCs; a-TUBB served as a loading control.
(F) Schematic of the affinity purification of FLAG-tagged DPF2 in ESCs and the MS procedure.
(G) DPF2-interacting proteins annotated in the STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database. Subunits of the BAF (blue), NuRD
(tan), MCM (green), and MSH complexes (yellow) are highlighted.
(H) GO term and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment of DPF2-interacting proteins. Selected terms are shown. FDR, false
discovery rate.
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regulating the interaction of the MCM complex with DNA repli-
cation origins.
Dpf2 Deletion Alters ESC Differentiation
Because KOofDpf2 altered the expression of some pluripotency
regulators, we examined the global gene expression changes
upon Dpf2 deletion in ESCs by RNA sequencing (RNA-seq).
We identified 383 significantly down- and 753 upregulated genes
when comparing Dpf2fl/fl and Dpf2/ ESCs (Figure S2A; Table
S2). Dpf2 loss led to the downregulation of genes associated
with stem cell maintenance, blastocyst formation, and signaling
pathways that control pluripotency and, in agreement with an
increase in apoptosis, induced the upregulation of genes
associated with cell death and negative regulation of prolifera-
tion (Figure 2A). Interestingly, we identified a number of differen-
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Figure 2. Dpf2 Deletion Impairs ESC Differ-
entiation
(A) GO analysis for biological processes associ-
ated with genes differentially expressed upon
Dpf2 deletion in ESCs.
(B) qPCR analysis for transcript levels of the indi-
cated lineage-specific genes on days 4 and 7 of
EB differentiation of Dpf2fl/fl and Dpf2/ cells.
(C) Global gene expression profiles of Dpf2fl/fl and
Dpf2/ EBs. Neuro, neural ectoderm markers;
Meso, mesoderm markers; Endo, endoderm
markers; Pluri, pluripotency-associated genes.
(D) Images of H&E-stained teratomas fromDpf2fl/fl
ESCs. Magnification, 6303.
(E) As in (D), except for Dpf2/ ESCs. Magnifi-
cation, 2003.
(F) qPCR analysis for transcript levels of the indi-
cated lineage-specific genes in day 6 EBs from
Dpf2fl/fl, Dpf2/, and Dpf2/ with ectopically
(exo) expressed Tbx3.
tiation-associated GO terms for both
down- and upregulated genes in Dpf2
KO ESCs (Figure 2A), suggesting a role
of Dpf2 in controlling differentiation
pathways.
To examine the differentiation poten-
tial of Dpf2/ ESCs, we performed
embryoid body (EB) differentiation as-
says and assessed the expression level
of well-established lineage markers. The
transcript levels of the endodermmarkers
Gata4, Gata6, and Sox17 and the meso-
derm marker Brachury (T) were signifi-
cantly lower in Dpf2/ EBs cultured for
4 or 7 days compared with their respec-
tive controls (Figure 2B), suggesting that
deletion of Dpf2 leads to impaired endo-
derm and mesoderm differentiation. The
expression of the ectoderm marker Fgf5
was lower in Dpf2/ EBs on day 4 but
similar in WT and Dpf2/ EBs cultured
for 7 days (Figure 2B). Conversely, the
expression of the neural ectoderm
markerPax6was upregulated throughout EBdifferentiation, indi-
cating that Dpf2 loss promoted neural ectoderm differentiation
(Figure 2B). We also induced ESC differentiation with retinoic
acid (RA), which promotes differentiation into primitive endoderm
(Cho et al., 2012). Immunostaining against SOX17, GATA6, and
GATA4 in Dpf2/ RA-differentiated cells revealed the reduction
of these markers compared with WT cells, indicating that differ-
entiation to primitive endoderm is significantly impaired without
Dpf2 (Figure S2B).
To gain more insights into the differentiation bias of Dpf2/
ESCs, we examined the global gene expression profile of
Dpf2/ EBs and corresponding WT controls. On day 4, a few
marker genes for endoderm and mesoderm showed decreased
expression and some neural-related genes showed increased
expression in mutant EBs compared with controls (Figure 2C,
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left; Table S3). These differences were even more pronounced in
EBs on day 7, when endoderm and mesoderm-related genes
showed significantly decreased and neuron-related genes
increased expression inDpf2/ EBs (Figure 2C, right; Table S3).
To investigate the effects of Dpf2 deletion on differentiation
in vivo, we assayed Dpf2/ and Dpf2fl/fl ESCs for their ability
to form teratomas. Dpf2fl/fl ESCs formed well-differentiated tera-
tomas containing cells of all three germ layers (Figure 2D).
Conversely, Dpf2/ ESCs formed mostly immature teratomas
containing mostly immature neural ectoderm tissue (with prom-
inent neuroepithelial rosettes) and trophoblast giant cells with
minimal endoderm- and mesoderm-related tissues (Figures 2E
and S2C). Thus, deletion of Dpf2 alters the differentiation pro-
pensity of ESCs in vitro and in vivo, away from meso-endoderm
toward immature neural ectoderm.
To validate that the impaired differentiation phenotype was
caused by deletion of the Dpf2 gene, we asked whether over-
expression of FLAG-tagged Dpf2 rescued the defects (Fig-
ure S2D).Dpf2 overexpression inDpf2fl/fl ESCs before disruption
of the endogenous Dpf2 alleles did not affect self-renewal or dif-
ferentiation (Figures S2E and S2F). However, when endogenous
Dpf2 was deleted in Dpf2 fl/fl ESCs by 4-OHT, Dpf2 overexpres-
sion rescued the differentiation defects of all three lineages,
restoring the levels of lineage-specific markers to WT levels
(Figure S2G).
Specificity of Dpf2 Function in ESC Differentiation
In addition to Dpf2 (BAF45d), BAF45a is expressed in mouse
ESCs, whereas BAF45b and BAF45c are lowly expressed (Ka-
doch and Crabtree, 2015). To examine whether the differentia-
tion defect observed upon the Dpf2 deletion is specific for
Dpf2, we generated Dpf2fl/fl ESC lines overexpressing BAF45a
and BAF45c (Figure S2H). Overexpression of either subunit prior
to the deletion of Dpf2 did not alter the expression of pluripo-
tency and differentiation marker genes (Figures S2I–S2L).
BAF45a or BAF45c overexpression did not rescue the differenti-
ation defects toward endoderm, mesoderm, and neural ecto-
derm of cells lacking endogenous Dpf2 (Figure S2M). These
results indicate that the BAF45 subunits are not functionally
redundant and highlight a specific role of Dpf2 in lineage speci-
fication from ESCs.
Tbx3 Rescues the Meso-endoderm Differentiation
Defects of Dpf2–/– ESCs
Tbx3 was one of the pluripotency genes most affected by dele-
tion ofDpf2 in undifferentiated ESCs (Figure 1E). Considering the
requirement of Tbx3 for meso-endoderm differentiation (Weidg-
ang et al., 2013; Waghray et al., 2015), we hypothesized that
Dpf2may control the differentiation potential of ESCs via regula-
tion of Tbx3 expression. To test this idea, we stably transfected
FLAG-tagged Tbx3 into Dpf2fl/fl cells and subsequently deleted
Dpf2. The data show that the endoderm marker genes Gata4,
Gata6, Sox17, and Pdgfra reached nearly WT levels in Dpf2/
4-day and 6-day EBs ectopically expressing Tbx3 (Figures 2F
and S2N). Similarly, ectopic Tbx3 expression restored the
expression levels of the mesoderm marker genes T, Bmp4,
Gata2, and Hand1 in Dpf2/ 6-day EBs (Figures 2F and S2N).
Conversely, the increase in neural ectoderm markers (Pax6,
Nes, and Tubb3) observed in Dpf2/ EBs was not reduced by
Tbx3 overexpression (Figures 2F and S2N). We conclude that
overexpression of Tbx3 rescued the endoderm and mesoderm
differentiation defects induced by loss of Dpf2 and that the
enhancement of neural-ectoderm differentiation in Dpf2/
EBs did not occur through regulation of Tbx3.
Because Tbx3 overexpression itself promotes endodermal
and mesodermal genes in differentiating ESCs (Weidgang
et al., 2013), it remained possible that Tbx3 expression may up-
regulate endo- andmesodermal genes in cells that have differen-
tiated toward neuroectoderm upon Dpf2 deletion. To exclude
this possibility, we performed immunofluorescence staining of
GATA4 in combination with NESTIN and TUBB3 in differentiating
Dpf2/ cells expressing Tbx3 exogenously and found that cells
expressed GATA4 in the absence of the neuroectodermmarkers
(Figures S2O and S2P). Thus, in the absence of Dpf2, Tbx3 over-
expression induces faithful differentiation toward endodermal
and mesodermal lineages.
DPF2 Co-occupies Active Enhancers with OCT4, SOX2,
and BRG1 in ESCs
To understand how Dpf2 regulates Tbx3, we profiled the
genome-wide binding sites of DPF2 in ESCs using chromatin
immunoprecipitation followed by high-throughput sequencing
(ChIP-seq) (Table S4). We found that the majority of DPF2 bind-
ing events occurred at genomic locations distal to transcriptional
start sites (TSSs), including both intergenic regions and gene
bodies (Figure 3A). By intersecting DPF2-bound genomic loca-
tions with previously annotated ESC chromatin states (Chronis
et al., 2017), we found that DPF2 predominantly binds en-
hancers, particularly those with high levels of the histone marks
H3K27ac, H3K4me2, and H3K4me1, characteristic of the most
active enhancers (Figure 3B, states 3 and 4). GO analysis indi-
cated that DPF2-occupied sites are located close to genes asso-
ciated with functions in stem cell maintenance, morphogenesis,
gastrulation, and development (Figure 3C).
To gain insights into the determinants of DPF2 binding, we
searched for sequence elements enriched within DPF2 target
sites. We found motifs for the Klf and Tead family members
Esrrb, Nanog, and Sox2 as well as the Oct-Sox composite site
to be most enriched (Figure 3D), suggesting that DPF2 is bound
at sites engaged by the core pluripotency TFs. This result was
corroborated by comparing the binding profile of DPF2 with
those of Oct4, Sox2, Nanog, Klf4, and Esrrb genome-wide
(Figures 3E and 3F) and at the Nanog locus as an example (Fig-
ure 3G). Among these pluripotency TFs, DPF2 binding sites over-
lapped more often with those of Oct4 and Sox2 than with those
of Nanog, Esrrb, and Klf4 (Figure 3E). In agreement with previous
data showing that DPF2 is a component of the OCT4 protein
network (van den Berg et al., 2010; Pardo et al., 2010), we
confirmed the interaction of the two proteins by co-immunopre-
cipitation (Figure S3A) and found that 48.5% of all OCT4 binding
events were co-occupied by DPF2.
Additionally, we performed ChIP-seq for BRG1, the ATPase
subunit of the BAF complex, and found a high overlap of DPF2
and BRG1 genome occupancy, consistent with mass spectrom-
etry (MS) (Figure 1G) and immunoprecipitation data for DPF2
(Figure S3B) and the notion that DPF2 mainly acts as a subunit
of the BAF complex in ESCs (Figures 3E-H). As expected from
the localization of DPF2 to active enhancers (Figure 3B), we
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also detected an extensive co-localization of DPF2 with the
transcriptional co-activator P300 (Figures 3E-3G). The signifi-
cant co-binding between DPF2 and P300 was further supported
by the physical interaction observed between DPF2 and P300 in
co-immunoprecipitation experiments (Figure S3C). DPF2 bind-
ing did not extensively overlap with that of EED and EZH2, sub-
units of the repressive polycomb complex PRC2 (Figures 3E,
S3D, and S3E). Together, these findings reveal collaboration
with pluripotency TFs at enhancers and suggest that Dpf2 plays
a role in the selection and activation of enhancers in ESCs.
Dpf2 Loss Does Not Globally Affect the Binding of BRG1
and PRC2
To determine whether Dpf2 deletion globally affects the binding
of BRG1, we performed ChIP-seq for BRG1 in ESCs after Dpf2
deletion.Dpf2 loss did not prevent binding of BRG1, whichmain-
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Figure 3. DPF2 Associates with Active En-
hancers and the Oct4, Sox2, and Brg1
Network in ESCs
(A) Distribution of DPF2 target sites determined by
ChIP-seq in ESCs in relation to their distance to
TSSs.
(B) Chromatin state enrichment of DPF2 target
sites in ESCs. ESC chromatin states were defined
in Chronis et al. (2017) using ChromHMM. Rows
represent chromatin states and their mnemonics.
Columns give the frequency of the indicated his-
tone marks and H3.3 for each chromatin state
(ChromHMM emission probabilities), color-coded
from blue (highest) to white (lowest). Enrichment of
DPF2 in each chromatin state is shown in the last
column.
(C) Significant GO terms for genes with DPF2
target sites within 10 kb of their TSS.
(D) Motifs identified at DPF2-bound sites by de
novo search and the best matching TFs.
(E) Hierarchical clustering of pairwise enrichments
of DPF2, BRG1, OCT4, SOX2, NANOG, ESRRB,
KLF4, EED, and EZH2 binding sites in ESCs. BRG1
and EED binding sites were identified from Dpf2fl/fl
and Dpf2/ ESC lines, and all other binding
events were obtained from WT ESCs. The black
box indicates highest correlation enrichment for
pairwise binding.
(F) Heatmaps of normalized ChIP-seq signal for
Dpf2, Brg1, Oct4, Sox2, Nanog, and p300 at all
sites bound by DPF2 in ESCs.
(G) Genome browser view of DPF2, BRG1, OCT4,
SOX2, NANOG, and P300 binding at the Nanog
locus in ESCs.
(H) Heatmaps of normalized ChIP-seq signal for
Dpf2 and Brg1 at BRG1 occupied sites in Dpf2fl/fl
or Dpf2/ ESC lines.
tained a similar genome-wide binding
profile as in WT Dpf2fl/fl ESCs (Figures
3E, 3H, and S3D). This result suggests
that the BAF complex assembly remains
unperturbed at the vast majority of its
physiological targets in the absence of
Dpf2. Similarly, Dpf2 loss did not affect
the binding profile of the PRC2 subunit
EED at the genome-wide level (Figure S3E), consistent with their
largely non-overlapping binding sites (Figure 3E).
Dpf2 Depletion Modulates H3K27ac Levels and Binding
of OCT4 and BRG1
Given the gene expression changes observed by the absence
of Dpf2, we investigated whether DPF2 engages genes that
become deregulated in KO ESCs. We found that 63% of
the differentially expressed genes in Dpf2/ ESCs associ-
ated with a DPF2 binding event within 20 kb around their
TSSs (Figure 4A; 719 of 1,136 genes, p < 0.0001, chi-square
test), including both up- and downregulated genes, suggest-
ing that Dpf2 can activate and repress gene expression. Plu-
ripotency genes downregulated in the absence of Dpf2,
including Klf4, Klf5, and Tbx3, were direct binding targets of
DPF2 (Figure 4A).
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Figure 4. Dpf2 Depletion Modulates Levels of H3K27ac and OCT4
(A) Heatmap of expression levels (log2RPKM+1) in Dpf2
fl/fl and Dpf2/ ESCs for differentially expressed genes between Dpf2fl/fl and Dpf2/ ESCs and their
DPF2 binding based on a DPF2 peak within 10 kb of the TSS (red, bound; black, unbound genes).
(B) Number of genomic sites with a significant change in H3K27ac (>2-fold difference) between Dpf2fl/fl and Dpf2/ ESCs, divided into those with a reduction
(top) and increase (bottom) in Dpf2/ ESCs, and their association with DPF2 in WT ESCs.
(legend continued on next page)
144 Cell Stem Cell 24, 138–152, January 3, 2019
We next asked how Dpf2 affects the histone modification
landscape. Hence, we generatedmaps for five histonemodifica-
tions from Dpf2fl/fl or Dpf2/ ESC lines, including H3K27ac,
H3K4me1, H4-tetraAC and H3K9ac, which are associated with
promoters and enhancers, and the repressive histone mark
H3K27me3 (Ernst et al., 2011).We did not observe significant dif-
ferences in the average H3K27ac signal between Dpf2fl/fl and
Dpf2/ cells when all DPF2 binding sites were considered (Fig-
ure S4A). However, we identified 4,581 sites with significant
reduction (R2-fold) of H3K27ac in Dpf2/ compared with
Dpf2fl/fl ESCs (Figures 4B and 4C). We also observed 2,513 sites
that gained H3K27ac signal by 2-fold or more uponDpf2 deletion
(Figures 4B and 4C). 21% of sites with decreased H3K27ac
levels and 46% of sites with an increase in H3K27ac were bound
by DPF2 in WT ESCs (Figure 4B) and located predominantly in
enhancers (Figure S4B), indicating that Dpf2 contributes to the
regulation of H3K27ac at active enhancers in ESCs.
H3K4me1, H4-tetraAC, H3K9ac, and binding by Oct4 and
Sox2 followed similar trends to H3K27ac at DPF2-occupied
sites, and the repressive mark H3K27me3 exhibited an antithet-
ical pattern (Figure 4D). P300 presence was dramatically
affected at DPF2-bound sites with diminished H3K27ac levels
in Dpf2/ ESCs but displayed very little change DPF2 sites
with a gain of H3K27ac (Figure 4D). Thus, DPF2 controls the
chromatin state and pluripotency TF binding at a subset of its
target sites.
Given the extensive co-localization of DPF2with OCT4 and the
interaction between these two proteins, we investigated the ef-
fect of Dpf2 loss on OCT4 binding in ESCs further. On average,
OCT4 binding was not different between Dpf2fl/fl and Dpf2/
cells at sites normally bound by DPF2 (Figure S4C). However,
a more detailed analysis identified a significant decrease of
OCT4 binding at 6,082 genomic locations in cells lacking Dpf2
expression, with 27% of those exhibiting DPF2 binding in
ESCs (Figures 4E and 4F) and an accompanying reduction in
H3K27ac levels in Dpf2/ ESCs (Figure 4G). A much smaller
number of sites displayed an increase in OCT4 binding in
Dpf2/ ESCs (737), accompanied by an increase in H3K27ac,
with many bound by DPF2 in ESCs (Figures 4E–4G). As seen in
our H3K27ac analysis, DPF2-bound sites with changes in Oct4
levels were more enriched in enhancers than promoters (Fig-
ure S4B). Interestingly, DPF2 binding sites exhibiting loss of
H3K27ac and OCT4 binding, respectively, were strongly en-
riched close to downregulated genes (Figure S4D). Conversely,
DPF2-bound locations at genes with elevated expression upon
Dpf2 loss were enriched for changes in H3K27ac and OCT4
binding, but less strongly (Figure S4D). These results suggest
that Dpf2 can act as both a suppressor and activator of gene
expression through the regulation of H3K27ac, P300, and
OCT4 levels and that enhancers are key sites of its action.
The destabilization of OCT4 binding and reduction of H3K27ac
upon loss of Dpf2 is exemplified at enhancers within the Bmp4
(Figure 4H), Tbx3 (Figure 6A), Gjb3, Lama1,and Nkx6-3 loci (Fig-
ures S4E–S4G). ChIP-qPCR confirmed this result for OCT4 bind-
ing at these genes and extended the findings to P300 (Figures
S4H and S4I). Although the binding of SOX2 and NANOG at
these loci also decreased (Figures S4J and S4K), we did not
detect any interaction of the DPF2 protein with either SOX2 or
NANOG in co-immunoprecipitation experiments (Figure S4L),
suggesting that the loss of these TFs is due to OCT4 loss.
Even though overall BAF complex binding remained largely
unaffected by the loss of Dpf2 (Figure 3), 8% of the BRG1 sites
exhibited a reduction in BRG1 occupancy and a concurrent
reduction of H3K27ac, P300, and OCT4 (Figures 4I and 4J)
and were located in enhancers enriched close to genes downre-
gulated upon Dpf2 loss (Figures S4B and S4D). Thus, at least for
a number of sites, DPF2 loss associates with the de-stabilization
of the entire BAF complex in addition to the reduction of OCT4
and P300. These sites include the examples described above
(Figures 4H, S4E-S4G, and 6A). The targeting of new sites by
BRG1 was negligible in Dpf2/ ESCs. The impaired binding of
BRG1 at only a subset of sitesmay be explained by the existence
of multiple BAF complexes in ESCs that consist of different core
components. These results confirm a role of Dpf2 in the recruit-
ment of OCT4 and BRG1 at a subset of sites within ESC
enhancers.
DPF2 Occupancy Changes with Differentiation
To gain mechanistic insights into the actions performed by DPF2
during differentiation, we performed ChIP-seq for DPF2 in EBs
cultured for 2 or 4 days (Table S4). DPF2 bound a large number
of new genomic locations as early as 2 days post-differentiation
(clusters II, III, and V) (Figure 5A). Two-thirds of ESC binding
events were lost upon differentiation (clusters I and IV) and
one-third was maintained (clusters VI and VII) upon differentia-
tion (Figure 5A). ESC-specific DPF2 binding sites were located
in the vicinity of genes associated with blastocyst formation
and trophectoderm differentiation (cluster I; Figure 5B), whereas
newly bound sites in EB-neighbored genes associated with
neuronal development (clusters III and V; Figure 5B), supporting
(C) Heatmap of normalized tag density profiles of H3K27ac experiments in Dpf2fl/fl and Dpf2/ cells at sites with significant H3K27ac changes from (B).
(D) Metaplots of average signal intensities for H4tetrac, H3K9ac, H3K4me1, H3K27me3, OCT4, SOX2, and P300 at DPF2-bound sites in ESCs with reduced (top)
or increased (bottom) H3K27ac, as defined in (B), for Dpf2fl/fl (blue) and Dpf2/ ESCs (red).
(E) As in (B), but for sites with significant differences in OCT4 instead of H3K27ac.
(F) Metaplots of average signal intensities for OCT4 in Dpf2fl/fl andDpf2/ ESCs at sites with significant OCT4 changes that are also occupied by DPF as defined
in (E).
(G) Heatmap of normalized tag density profiles of H3K27ac e in Dpf2fl/fl and Dpf2/ ESCs at sites with significant OCT4 binding changes and occupied by DPF2
(E) and corresponding metaplots of signal intensities.
(H) Genome browser view of ChIP-seq tracks of DPF2, BRG1, EED, and OCT4 binding as well as H3K27ac and H3K27me3 for the Bmp4 locus. DPF2 data are
fromWT ESCs and the others from Dpf2fl/fl and Dpf2/ ESCs, indicated as fl/fl and/. Regions highlighted in blue signify ESC enhancer regions as defined by
ChromHMM in Chronis et al. (2017). The values on the y axis represent fold enrichment over control.
(I) Heatmap of normalized tag density profiles of DPF2, EED, H3K27ac, and P300, at sites exhibiting a reduction in BRG1 in Dpf2/ ESCs compared withDpf2fl/fl
ESCs. DPF2 data are from WT ESCs and all others from Dpf2fl/fl and Dpf2/ ESCs, indicated as fl/fl and /.
(J) Metaplots of average signal intensities for DPF2 and BRG1, H3K27ac, p300 and Oct4 at sites defined in (I).
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a direct role of DPF2 in the regulation of neural ectoderm differ-
entiation. Constitutively bound DPF2 sites were associated
with endodermal and mesodermal as well as notochord devel-
opment (cluster VII; Figure 5B) and contained binding events
in the vicinity of the endodermal and mesodermal marker genes
Gata4, Gata6, Sox17, and T (Figure S5A). Consistent with the
maintenance of Dpf2 binding, we did not observe a change in
H3K27ac levels at these sites (Figure S5A). These data sug-
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Figure 5. Regulation of Meso-endoderm
Differentiation by Dpf2 and Eed via Tbx3
(A) Clustering of Dpf2 binding events in ESCs and
day 2 and 4 EBs. The genome was divided into
500-bp bins and a bin called bound (blue) or un-
bound (white) based on the presence of a DPF2
peak.
(B) GO analysis for enriched biological process for
genes associated with DPF2 peaks from different
clusters defined in (A), within ± 20 kb of the TSS.
(C) Transcript levels of the indicated endoderm
markers in day 4 EBs from Dpf2fl/fl, Eed/, and
Eed/Dpf2 double KO determined by qPCR.
(D) As in (C), except for pluripotency-associated
genes in Dpf2fl/fl, Dpf2/, Eed/, and Dpf2 and
Eed double KO ESCs.
(E) As in (C), except for Tbx3 in day 4 EBs from
Dpf2fl/fl, Eed/, and Eed/Dpf2 double KO ESCs.
(F) As in (C), except for various endodermmarkers in
4-day EBs induced from Eed/ and Eed//Tbx3
kd ESCs.
(G) As in (C), except for various mesoderm markers
and Tbx3 in day 7 EBs from Dpf2fl/fl, Eed/, and
Eed/Dpf2 double KO ESCs.
(H) As in (C), except for various neuroectoderm
markers in day 6 EBs from Dpf2fl/fl, Dpf2/, and
Eed/Dpf2 double KO ESCs.
gest that the gene expression changes in
endo-mesodermal genes observed upon
Dpf2 deletion do not occur through a direct
function of DPF2. Consistent with this
idea, overexpression of Dpf2 in ESCs did
not lead to the upregulation of endo- and
mesodermal markers (Figure S2F).
Dpf2 and Eed Control Meso-
endoderm Differentiation by
Opposingly Regulating Tbx3
Previous studies showed that the deletion
of Eed increases the expression of endo-
derm and mesoderm markers (Boyer et al.,
2006; Chamberlain et al., 2008; Leeb et al.,
2010). Because we observed the downre-
gulation of endo- and mesodermal genes
in differentiating Dpf2/ ESCs (Figure 2),
wehypothesized that endo- andmesoderm
differentiation may be oppositely regulated
by Eed and Dpf2. To test this idea, we
deleted the Eed gene in Dpf2fl/fl cells by
targeting its second exon with an out-of-
frame mutation leading to loss of the EED
protein (Figures S5B–S5D). Immunostaining verified the loss of
H3K27me3 in Eed/ ESCs (Boyer et al., 2006; Figure S5E). Sub-
sequently, we induced differentiation ofDpf2fl/fl, Eed/, and Eed/
Dpf2 double KO ESCs by EB formation.
As expected, KO of Eed led to increased expression of the
endodermal genes Gata4, Gata6, Sox7, and Sox17 (Figures 5C
and S5F) (Boyer et al., 2006). The expression of these genes
was restored close to WT levels in Dpf2 and Eed double KO
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EBs (Figures 5C and S5F), demonstrating that Eed and Dpf2
regulate endoderm differentiation in an opposing manner.
Next we studied how Eed and Dpf2 mechanistically regulate
endoderm differentiation. Deletion of Eed did not dramatically
affect the expression of Oct4, Sox2, and Nanog in ESCs but
significantly increased Tbx3 expression, contrary to the downre-
gulation of Tbx3 in Dpf2/ ESCs (Figure 5D). When we induced
the deletion of Dpf2 in Eed/ cells, Tbx3 expression decreased
toward WT levels (Figure 5D). We conclude that Eed and Dpf2
oppositely regulate Tbx3 expression in ESCs and during the
onset of differentiation.
We further investigated whether the increase in Tbx3 expres-
sion in the absence of Eed was responsible for the increase in
endodermal gene expression. We found that Tbx3 transcript
levels correlated with the expression of Gata4, Gata6, Sox7,
and Sox17 during differentiation of Dpf2fl/fl, Eed/, and Eed/
Dpf2 double KO cells (Figures 5C, 5E, S5F, and S5G). Therefore,
we induced EB formation from Eed//Tbx3 knockdown (kd)
ESCs in which Tbx3 transcripts were depleted by RNAi-medi-
ated knockdown (Figure S5H). Expression of Gata4, Gata6,
and Sox7 decreased when Tbx3 was depleted compared with
Eed/ cells (Figure 5F), indicating that Eed controls endoderm
differentiation, at least partially, via regulating Tbx3 expression,
and that the balance of Dpf2 and Eed is critical for the regulation
of Tbx3.
These conclusions extend to the regulation of mesoderm dif-
ferentiation. Contrary to the downregulation of the mesoderm
genes T, Bmp4, Hand1, and Gata2 in differentiating Dpf2/
ESCs (Figure 2), the expression of these genes significantly
increased in Eed/ EBs and was largely restored in Dpf2 and
EeddoubleKOEBs (Figure 5G). Similarly, the inducedexpression
of the neural ectoderm markers Nes, Pax6, Ncam1, and Pcdh17
observed in Dpf2/ EBs was restored to physiological levels in
Dpf2 and Eed double KOEBs (Figures 5H and S5I). Thus, in addi-
tion to endoderm differentiation, Eed and Dpf2 oppositely regu-
late mesoderm and neural ectoderm differentiation.
Dpf2 and Ezh2 Regulate Endo- and Mesoderm
Differentiation by Regulating Nanog
Given that Eed, Ezh2, and Suz12, the core subunits of PRC2,
have different effects on ESC differentiation (Boyer et al., 2006;
Chamberlain et al., 2008; Leeb et al., 2010), we wanted to find
out what the effects of Ezh2 were in our system. We deleted
the fifth exon of the Ezh2 gene homozygously in Dpf2 fl/fl cells,
which resulted in loss of EZH2 at the protein level (Figure S6A),
and induced EB formation of Dpf2fl/fl, Ezh2/, and Ezh2 and
Dpf2 double KO ESCs. In contrast to the upregulation of endo-
derm markers in the absence of Eed (Figures 5C and S5F), KO
of Ezh2 led to repression of Gata4,Gata6, Sox7, and Sox17 (Fig-
ures S6B and S6C). The expression of these genes was restored
close toWT levels inDpf2 and Ezh2 double KO EBs (Figures S6B
and S6C), indicating that Ezh2 and Dpf2 regulate endoderm dif-
ferentiation in an opposingmanner but differently compared with
Eed. Ezh2 and Dpf2 also opposingly regulated mesoderm differ-
entiation (Figure S6D). The decreased expression ofmeso-endo-
derm genes in Ezh2/ EBs (Figures S6B–S6D) occurred despite
an increase in Tbx3 expression upon deletion of Ezh2 (Fig-
ure S6E). Thus, Eed and Ezh2 both repress Tbx3 in ESCs but
have rather distinct effects on meso-endoderm differentiation.
Consistent with previous reports (Shen et al., 2008; Villasante
et al., 2011), Nanog was upregulated in Ezh2/ ESCs (Fig-
ure S6E). Because Nanog overexpression in ESCs is reported
to repress endoderm and mesoderm lineages (Chambers and
Smith, 2004), we postulated that the regulation of Nanog could
explain the observed impairment of differentiation toward these
lineages in Ezh2/ ESCs (Figures S6B and S6D). Indeed, the
expression of endo- and mesodermal genes in Ezh2/ EBs
increased when Nanog was knocked down by short hairpin
RNA (shRNA) (Figures S6F and S6G).Nanogwas downregulated
when Dpf2 was deleted in Ezh2/ ESCs (Figure S6E), which
may restore the differentiation of Ezh2 and Dpf2 double KO
ESCs to mesoderm and endoderm. Furthermore, we found
that neural ectoderm genes were repressed in Ezh2/ EBs,
which could be restored close to WT levels upon deletion of
Dpf2 (Figures S6H and S6I), demonstrating the opposing regula-
tion of neural ectoderm differentiation by Dpf2 and Ezh2.
Taken together, Eed and Ezh2 hinder and promote meso-
endoderm differentiation of ESCs, respectively. The PRC2 sub-
units achieve these opposing effects by acting through different
downstream TFs (Tbx3 versus Nanog). In contrast, during neu-
ral-ectoderm differentiation, both PRC2 subunits repress the
program, suggesting that they may have the same downstream
targets in this process.
Dpf2 and Eed Regulate Tbx3 through Different
Enhancers
Because DPF2 predominantly binds active enhancers in ESCs,
we speculated that Dpf2 regulates Tbx3 expression by regu-
lating H3K27ac levels at its enhancers. Indeed, we found that
Dpf2 deletion in ESCs decreased H3K27ac of the previously
described intronic enhancer (IE) (Buecker et al., 2014) and a
distal enhancer (DE) located about 87 kb upstream of the TSS
(Figure 6A). Interestingly, Dpf2 deletion decreased OCT4 and
SOX2 binding, but only at the DE and not at the IE (Figure 6A),
suggesting that the DE may be critical for the regulation of
Tbx3 by Dpf2 in ESCs. In agreement with this, with the circular
chromosome conformation capture assay (4C) using the Tbx3
promoter as a viewpoint, the Tbx3 promoter was found in spatial
proximity to the DE inDpf2fl/fl ESCs but to the IE inDpf2/ ESCs
(Figure 6B). Moreover, deletion of the DE (Figure S7A) signifi-
cantly decreased Tbx3 transcript levels (Figure 6C) and impaired
meso-endoderm differentiation (Figure 6D). These data indi-
cated that Dpf2 regulates Tbx3 expression mainly via the modu-
lation of H3K27ac on the DE, which changes the access of OCT4
and other TFs or vice versa.
Considering how EED regulates Tbx3, we found that deletion
of Eed did not affect the level of H3K27ac on either the IE or
DE (Figure 6E). However, we identified a strong enrichment of
H3K27me3 and EED at the IE and across the Tbx3 gene in
ESCs but not at the DE (Figure 6A). As expected, KO of Eed
led to the loss of H3K27me3 at the IE (Figure S7B). Moreover,
the deletion of Dpf2 induced an increase of EED and
H3K27me3 as well as the other two PRC2 subunits, EZH2 and
SUZ12, at the IE and across the Tbx3 gene body (Figures 6A
and 6F) without a change in OCT4 and SOX2 binding at the IE
(Figure 6A). Thus, Dpf2 deletion in ESCs did not alter the acces-
sibility of key pluripotency transcription factors but increased
the access of PRC2 to the IE and across the Tbx3 gene body.
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Deletion of Dpf2 also led to decreased binding of the BRG1 on
the DE region, which was not the case at the IE region because
BRG1 binding was largely unaffected (Figure 6A). We also found
that deletion of the IE in ESCs did not strongly affect the expres-
sion of Tbx3 in ESCs (Figure S7C), suggesting that the IE does
not contribute to the downregulation of Tbx3 in Dpf2/ ESCs.
However, OCT4 and SOX2 binding increased at the IE in Eed/
ESCs (Figure 6G), whichmay provide themechanism for how the
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Figure 6. Dpf2 and Eed Regulate Tbx3 Expression by Controlling Histone Modifications and Accessibility of Pluripotency TFs at Different
Enhancers
(A) Genome browser view of ChIP-seq tracks for DPF2 and P300 in WT ESCs and BRG1, OCT4, SOX2, EED, H3K27ac, and H3K27me3 in Dpf2fl/fl and Dpf2/
ESCs (indicated as fl/fl and /) at the Tbx3 locus. The distal enhancer (DE) and intronic enhancer (IE) enhancers are highlighted. The values on the y axis
represent fold enrichment over control.
(B) Circular chromatin conformation capture (4C-seq) analysis of the Tbx3 promoter. The arcs represent significant interactions from the Tbx3 promoter viewpoint
in Dpf2fl/fl and Dpf2/ ESCs. The DE and IE are indicated.
(C) Transcript levels of Tbx3 in two DE KO ESC clones and control ESCs based on qPCR.
(D) As in (C), except for the indicated lineage markers in day 6 EBs from WT and the two DE KO ESCs.
(E) H3K27ac levels at Tbx3 enhancers in Dpf2fl/fl, Eed/, and Eed/Dpf2 double KO ESCs, determined by ChIP-qPCR.
(F) As in (E), except for relative levels of EED, EZH2, and SUZ12 at the IE of the Tbx3 gene in Dpf2fl/fl and Dpf2 / ESCs.
(G) As in (E), except for relative levels of OCT4 and SOX2 at the IE of the Tbx3 gene in WT and Eed/ ESCs.
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loss of Eed results in upregulation of Tbx3. Taken together, our
data indicate that Dpf2 regulates Tbx3 by modulating H3K27ac
and binding of pluripotency TFs at the DE, whereas Eed controls
Tbx3 through the regulation of H3K27me3 across the gene body
and pluripotency factor access at the IE, which results in oppo-
site outcomes regarding Tbx3 expression.
Dpf2 and Eed Regulate Gene Expression Oppositely via
Modulating Histone Modifications and Binding of
Pluripotency TFs
Finally, we compared the transcription profiles of Dpf2/ and
Eed/ ESCs to determine whether there are additional tran-
scripts with similar trends as observed for Tbx3. We found 328
Figure 7. Model for the Regulation of ESC Differentiation by Dpf2 and Eed via the Control of Tbx3 Expression
Dpf2 and Eed regulate Tbx3 expression via modulation of the H3K27ac level at the DE and the H3K27me3 level at the IE. Loss of Dpf2 induces downregulation
of Tbx3 via a decrease of both H3K27ac and pluripotency TF binding on the DE, leading to impaired differentiation into meso-endoderm. In Eed/
ESCs, H3K27me3 levels decrease at the IE, whereas the binding of pluripotency TFs increases, resulting in Tbx3 upregulation and enhanced differentiation to
meso- and endoderm. In Dpf2//Eed/ ESCs, Tbx3 expression is restored to physiological ESC levels, as is the potential for differentiation into endo- and
mesoderm.
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deregulated genes in both Dpf2/ and Eed/ ESCs (p < 0.05)
(Figure S7D) and 2,482 shared target genes with both DPF2
and EED sites in their vicinity (Figure S7E). Intersecting the two
sets of genes, we identified 144 genes directly regulated by
Dpf2 and Eed (Figure S7F). Among those, 34 genes were down-
regulated in Dpf2/ ESCs and upregulated in Eed/ ESCs,
similar to the opposing regulation of Tbx3 by Dpf2 and Eed
(Figure S7G). These genes included Bmp4, Sox21, and Lama1
(Figures S7G and S7I) and were associated with embryonic
development based on GO analysis (Figure S7H). Similar to
Tbx3, the respective regulation of H3K27ac and H3K27me3 by
Dpf2 and Eed was observed for Bmp4, Sox21, and Lama1 (Fig-
ures S7J and S7K). Moreover, the binding of OCT4 and SOX2 at
these genes decreased in Dpf2/ ESCs (Figures S7L and S7M)
but increased in Eed/ ESCs (Figures S7N and S7O). Thus, our
study uncovered that Dpf2 and Eed oppositely regulate a set of
genes important for embryonic development by modulating the
deposition of H3K27ac and H3K27me3 and altering the access
of pluripotency TFs.
DISCUSSION
In this study, we revealed that the BAF subunit DPF2 is critical for
ESC differentiation into mesoderm, endoderm, and neural ecto-
derm. Moreover, we show that meso-endoderm differentiation
defects because of Dpf2 deletion can be rescued by restoring
the expression of Tbx3 to normal levels. The differentiation de-
fects of Dpf2 KO ESCs are different from those described for
other BAF components (Ho and Crabtree, 2010), in agreement
with the notion that different subunits confer different functional-
ities. Importantly, this study defines a functional downstream
target of the BAF complex in ESCs, for which maintenance of
expression is important for ESC fate decisions.
Our study further revealed an opposing regulation of endo-
derm and mesoderm differentiation by Dpf2 and Eed. This rela-
tionship was supported by the restored expression of endoderm
and mesoderm marker genes in Eed/Dpf2 double KO EBs. We
postulate that Dpf2 and Eed oppositely regulate endo- and
mesoderm differentiation of ESCs via differential control of
Tbx3 expression.
An antagonistic role of polycomb and BAF complexes has
been reported previously through competitive binding of these
complexes at the same locus (Wilson et al., 2010; Ho et al.,
2011; Kadoch et al., 2017). In contrast, our work shows that
Eed and Dpf2 function inmeso-endoderm differentiation via their
respective interaction at different enhancers, the IE and DE,
respectively, at the Tbx3 locus, as summarized in Figure 7. Spe-
cifically, the loss of Eed diminished the enrichment of H3K27me3
over the Tbx3 gene, including its IE, which increased the access
of OCT4 and SOX2 to the IE, which likely leads to upregulation
of Tbx3. The loss of Dpf2 led to an increase of H3K27me3
deposition at the IE of Tbx3 by increasing the access of PRC2,
consistent with competitive binding between PRC2 and BAF
complexes at the IE. Conversely, the loss of Dpf2 significantly
decreased the H3K27ac level and the access of OCT4 and
SOX2 at the DE. The decrease in OCT4 binding could precede
the drop of H3K27ac because the impaired physical interaction
of DPF2 and OCT4 upon loss of Dpf2 may destabilize OCT4
binding. Conversely, because P300 is known to acetylate his-
tone H3K27 (Tee and Reinberg, 2014), another possible scenario
for the decrease in H3K27ac is that loss of the direct interaction
between DPF2 and P300 leads to the decrease in H3K27ac in
Dpf2/ ESCs, which, in turn, may affect OCT4 binding. Regard-
less, the interaction between DPF2, P300, and OCT4 indicates a
collaborative regulation of Tbx3 via a chromatin remodeler, chro-
matin modifications, and critical TFs.
Our study also demonstrates that the opposing regulation of
targets byDpf2 and Eed in ESCs is not limited to Eed but extends
to the PRC2 subunit Ezh2. However, meso-endoderm markers
were repressed in the absence of Ezh2, in contrast to their in-
crease upon Eed deletion. We show that these differences in
the differentiation defect are achieved through distinct down-
stream transcription factors because the opposing effect of
Dpf2 andEzh2 ensuedmainly via differential regulation ofNanog.
Brg1 is a core unit of BAF complex and is required for the self-
renewal and pluripotency of ESCs (Ho and Crabtree, 2010). We
confirmed the interaction of DPF2 and BRG1 by immunoprecip-
itation and showed that these proteins extensively co-localize in
the genome. Although both Brg1 and Dpf2 positively regulate
Tbx3 expression in ESCs (Ho et al., 2011), Dpf2 did not affect
the expression ofOct4, which is upregulated upon acute deletion
ofBrg1 (Bultman et al., 2000), indicating thatDpf2mediates spe-
cific functions of the BAF complex during embryonic develop-
ment. As a core factor of the BAF complex, Brg1 likely affects
embryonic development by participating in various BAF com-
plexes with different components (Ho and Crabtree, 2010; Pan-
amarova et al., 2016). Consistent with this conclusion, loss
of Dpf2 does not dramatically alter the genome-wide binding
of BRG1.
In summary, PRC2 and BAF complexes are important for the
ESC differentiation and embryonic development (Ho and Crab-
tree, 2010). Our study uncovered unique mechanisms by which
a specific BAF subunit and PRC2 subunits regulate genes impor-
tant for the ESC differentiation.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal GAPDH Abcam ab9484
Rabbit polyclonal Requiem Sigma SAB4502621
Mouse monoclonal FLAG Sigma F1804
Rabbit polyclonal TBX3 Invitrogen 42-4800
Goat polyclonal OCT4 R&D systems AF1759
Goat polyclonal SOX2 R&D systems AF2018
Mouse monoclonal NESTIN BD PharMingen 556309
Mouse monoclonal TUBB3 Promega G712A
Rabbit polyclonal NANOG Abcam Ab80892
Mouse monoclonal P300 Active motif 61401
Mouse monoclonal STAT3 Cell Signaling Technology 9139
Rabbit monoclonal H3K27ac Abcam ab177178
Rabbit polyclonal H3K27me3 Millipore 07449
Rabbit polyclonal H3K4me3 Abcam ab8580
Rabbit polyclonal H3K9ac Abcam ab4441
Mouse monoclonal H4-tetraAC Active motif 39967
Polyclonal goat SOX17 R&D systems AF1924
Rabbit polyclonal GATA4 Santa Cruz sc-9053
Goat polyclonal GATA6 R&D systems AF1700
Rabbit polyclonal SUZ12 Abcam ab12073
Mouse monoclonal EZH2 BD PharMingen 612667
Rabbit polyclonal EED Millipore 17-10034
Rabbit monoclonal BRG1 Abcam ab110641
Mouse IgG ThermoFisher A-11032
Alex488-conjugated donkey anti-goat IgG ThermoFisher A-11055
Alex594-conjugated donkey anti-rat IgG ThermoFisher A-21209
Alex488-conjugated donkey anti-mouse IgG ThermoFisher A-21202
Alex594-conjugated donkey anti-rabbit IgG ThermoFisher A-21207
DAPI ThermoFisher D1306
Bacterial and Virus Strains
DH5a Competent Cells NEB C-29871
One Shot TOP10 Chemically Competent E. coli ThermoFisher C404010
Chemicals, Peptides, and Recombinant Proteins
LIF Millipore ESG1107
BMP4 R&D System 5020-BP-010
Zeocin ThermoFisher R25001
G418 ThermoFisher 11811031
Puromycin ThermoFisher A1113802
Protease inhibitors Roche 4693159001
Benzonase Sigma E8263-5KU
2x Laemmli Sample Buffer Bio-Rad #1610737
3X FLAG peptide Sigma F4799-4MG
Trypsin-EDTA (0.25%), phenol red ThermoFisher 25200056
Paraformaldehyde Sigma P6148-500G
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Disuccinimidyl glutarate ThermiFisher 20593
Triton X-100 Sigma T8787-50ML
4-Hydroxytamoxifen TOCRIS 3412
Tamoxifen Sigma T5648
Annexin-APC BD PharMingen 550475
7-AAD BD PharMingen 559925
SYBR Green PCR Master Mix ThermoFisher 4309155
ABsolute QPCR Mix, ROX ThermoFisher AB1139A
SequalPrep Long PCR Kit with dNTPs ThermoFisher A10498
Expand Long Template PCR System Roche 03321053103
Disuccinimidyl glutarate ThermoFisher 20593
Proteinase K ThermoFisher 25530049
T4 DNA ligase NEB M0202S
Csp6I Thermo Fisher FD0214
MboI Thermo FD0814
Vivaspin500 PES centrifugal filters Vivascience VS0102
KAPA HTP Library Preparation kit Roche 07961901001
Critical Commercial Assays
AP staining kit Sigma SCR004
SequalPrep Long PCR kit Invitrogen A10498
BCA Protein Assya Kit Pierce 23227
ECL Plus Amersham RPN2133
RNeasy mini kit QIAGEN 74104
TotalPrep RNA Amplification Kit Ambion AMIL1791
NucleoSpin gDNA Clean-Up kit Macherey-Nagel 740230.10
SuperscriptIII reverse transcriptase Invitrogen 18080093
Click-iT EdU Pacific Blue flow cytometry Assay Kit Invitrogen C10636
Pierce BCA Protein Assay Kit Invitrogen 23225
Deposited Data
ChIP-seq This study E-MTAB-6165
RNA-seq This study E-MTAB-6166
4C This study E-MTAB-6167
Experimental Models: Cell Lines
E14 ESCs This study N/A
R26::CreERT2 - E14 ESCs This study N/A
R26::CreERT2 Dpf2 fl/fl E14 ESCs This study N/A
Eed / R26::CreERT2 Dpf2 fl/fl E14 ESCs This study N/A
Ezh2 / R26::CreERT2 Dpf2 fl/fl E14 ESCs This study N/A
Tbx3 DE KO ESCs This study N/A
Tbx3 IE KO ESCs This study N/A
Experimental Models: Organisms/Strains
SCID mice Hans Scholer’s Group N/A
Deposited Data
ChIP-seq data This study E-MTAB-6165 (ArrayExpress)
RNA-seq data This study E-MTAB-6166 (ArrayExpress)
4C data This study E-MTAB-6167 (ArrayExpress)
Proteomics data This study PXD011806 (ProteomeXchange)
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Oligonucleotides
Oct4 TaqMan Mm00658129_gH
Klf4 TaqMan Mm00516104_m1
Nanog TaqMan Mm02384862_g1
Rex1 TaqMan Mm03053975_g1
Nr0b1 TaqMan Mm00431729_m1
Klf2 TaqMan Mm01244979_g1
Klf5 TaqMan Mm00456521_m1
Gapdh TaqMan 4352339E
Tbx3 TaqMan Mm01195726_m1
GATA6 TaqMan Mm00802636_m1
GATA4 TaqMan Mm00484689_m1
Sox17 TaqMan Mm00488363_m1
FGF5 TaqMan Mm00438918_m1
Sox1 TaqMan Mm00486299_s1
Pax6 TaqMan Mm00443072_m1
Brachyury TaqMan Mm01318252_m1
Tubb3 TaqMan Mm00727586_s1
Dpf2 TaqMan Mm00599980_m1
Nestin TaqMan Mm00450205_m1
Pdgfra TaqMan Mm00440701_m1
GATA2 TaqMan Mm00492301_m1
Bmp4 TaqMan Mm00432087_m1
Hand1 TaqMan Mm00433931_m1
Sox21 TaqMan Mm00844350_s1
Gjb3 TaqMan Mm00433647_m1
Lama1 TaqMan Mm01226102_m1
Ncam1 TaqMan Mm01149710_m1
Pcdh17 TaqMan Mm00977568_m1
See Table S5 for qPCR and gRNA sequences This Study N/A
Recombinant DNA
Dpf2 targeting vector EUCOMM resource N/A
C-FTAP-tag Dpf2 knockin vector This study N/A
pPyCAG-Dpf2-IZ Hitoshi Niwa N/A
pPyCAG-Tbx3-IN Hitoshi Niwa N/A
pCAGGs-FlpE This study N/A
Nanog shRNA Wu Qiang N/A
Tbx3 shRNA April Kartikasari N/A
Reagent or Resource
GMEM Sigma-Aldrich G2549
FCS GIBCO 10439024
Non-essential amino acid GIBCO 11140050
Sodium pyruvate GIBCO 11360070
2-mercaptoethanol GIBCO 21985023
L-glutamine GIBCO 25030081
TCEP Sigma 75259
Iodoacetamide Sigma I6125
colloidal Coomassie Sigma B2025
AggreWell 400 plates STEMCELL Technoligies 34421
(Continued on next page)
Cell Stem Cell 24, 138–152.e1–e8, January 3, 2019 e3
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Wensheng Zhang
(zhangwensheng@suda.edu.cn).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
E14 ESCs were cultured in GMEM (Sigma) supplemented with 10% FCS, 13 NEAA, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoe-
thanol, 2 mM L-glutamine, and LIF (Millipore) on gelatin coated plates, or cultured in N2B27 medium with BMP4 (10ng/ml) and LIF.
METHOD DETAILS
Colony formation assay
For colony formation assays, dissociated cells with trypsin were plated at about 1,000 cells per 10cm plate. ESCs were cultured for
7 days and stained for alkaline phosphatase using the AP staining kit (Sigma).We scored colonies with90%AP-positive cells as un-
differentiated, colonies with5%AP-positive staining cells as differentiated, and colonies of intermediate AP-positive cell number as
partially differentiated.
Teratoma formation assay
5 3 106 cells were injected subcutaneously into the flank of SCID mice. After 4-5 weeks, teratomas were isolated, transferred into
Bouin’s fixative overnight and subjected to histological examination with H&E staining based on standard protocols. All tissues
were examined by a board-certified anatomic pathologist (M.P.), blinded to the genotype of the ESCs.
Generation of a conditional knockout of Dpf2 in ESCs
The Dpf2 targeting vector was linearized and electroporated into R26::CreERT2 E14 cells to generate heterozygous ESC lines after
G418 selection. Heterozygous ESC clones were transiently transfected with a FLP recombinase encoding plasmid (pCAGGs-FlpE),
converting the initial knockout allele (Dpf2+/, lacZ positive, G418 resistant) into a ‘‘wild-type’’ (WT) allele with two loxP sites flanking
exon 4 (floxed allele) (Dpf2fl/+, reverted WT (rWT), lacZ negative, G418 sensitive). Multiple independent rWT ESC clones were
then electroporated with the original Dpf2 knockout vector and again selected with G418. Targeting of the second WT allele
was confirmed by the presence of both the rWT allele and the second knockout allele through long-range PCR reactions (SequalPrep
Long PCR kit, Invitrogen). Selected heterozygous ESC lines were converted to the conditional Dpf2fl/fl state by transiently transfect-
ing FlpE.
Generation of Eed and Ezh2 knockout ESC clones
2ug of gRNA and 2ug of Cas9 plasmids were electroporated to ESCs. After 7 days’ selection with 175ug/ml of G418, colonies were
picked up for genotyping and confirmed by Sanger sequencing.
Continued
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Dynabeads Protein G Invitrogen 10003D
4-12% Bis-Tris Novex gel Invitrogen NP0321BOX
PVDF membranes Biorad 1620177
Software and Algorithms
ChromHMM v1.1.0 Chronis et al., 2017 N/A
Bowtie2 v2.2.1 Langmead et al., 2009 N/A
Cufflinks v2.2.1 Trapnell et al., 2010 N/A
MACS2 v20140616 Zhang et al., 2008 N/A
BedTools v2.27 Quinlan and Hall, 2010 N/A
HOMER v4.9.0 Heinz et al., 2010 N/A
Metascape http://metascape.org N/A
Proteome Discover 1.4 Thermofisher N/A
Tophat version 2.0.13 Trapnell et al., 2009 N/A
Mascot 2.5 Matrix Science N/A
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Co-Immunoprecipitation (Co-IP) and Western Blotting
Cells were lysed in lysis buffer (1%NP40; 50mM Tris-HCl, pH7.4; 150mMNaCl; 1mMEDTAwith protease inhibitors (Roche)). Protein
concentrations were determined using the BCA Protein Assay Kit (Pierce). For immunoprecipitation, cell lysates were incubated with
the indicated antibodies for 1 hour. Protein G-associated Dynabeads (Thermo Fisher) were added at 4C overnight. After washing
three times with lysis buffer, 1X protein SDS loading buffer (Bio-Rad) was added and boiled for 5 minutes. The supernatant was
cooled on ice for 5 minutes before loading on the gel for immunoblotting. Proteins were fractionated on a 4%–12% Bis-Tris Novex
gel (Invitrogen), electroblotted onto PVDF membranes, and membranes probed sequentially with respective antibodies. Blots were
incubated with secondary antibodies and developed with ECL Plus (Amersham).
Affinity purification of the DPF2 complex
Formaldehyde-crosslinked ESCs expressing DPF2-FTAP were used for affinity purification of DPF2, and an ESC line expressing a
beta-gal-FTAP fusion protein (Bode et al., 2016) was used as a control. Whole cell extracts were prepared using a high salt lysis buffer
(450 mMNaCl, 0.2% Nonidet P-40) as previously described (Pardo et al., 2010), with several modifications. Briefly, cells were cross-
linked with 1% formaldehyde for 10 minutes at room temperature; after a 10 min incubation of cells in lysis buffer on ice, 1 ul/mL of
benzonase (99%purity, Sigma) was added and the cell suspension was incubated at 37C for 15min. The lysate was then cleared by
centrifugation at 16,100 rcf. for 15 min at 4C. FLAG affinity purification was essentially performed as previously described. Anti-
FLAG Dynal beads were prepared by crosslinking M2 FLAG antibody (Sigma) to Protein G-Dynal beads (Invitrogen) in accordance
with the manufacturer’s instructions. Whole-cell extracts were incubated with anti-FLAG M2 Dynal beads in buffer containing
150 mM NaCl and 0.1% NP-40 for 90 min at 4C. Beads were washed three times with RIPA buffer, then 3 times with RIPA buffer
containing 450 mM NaCl, and once with elution buffer (10 mM Tris-HCl pH 8, 150 mM NaCl, 0.02% Nonidet P-40). Proteins were
eluted in elution buffer containing 200 mg/mL 3X FLAG peptide (Sigma). Eluates were concentrated in Vivaspin500 PES centrifugal
filters (10 kDa cut-off, Vivascience), reduced with 5 mM TCEP (Sigma), and alkylated with 10 mM iodoacetamide (Sigma). Samples
were fractionated by polyacrylamide gel electrophoresis using Novex NuPAGE Bis-Tris 4%–12% gels (Invitrogen) and stained with
colloidal Coomassie (Sigma) as previously described (Pardo et al., 2010). Full gel lanes were sliced in 7-24 bands, gel pieces were de-
stained completely and digested with trypsin (sequencing grade, Roche). Peptides were extracted using 0.5% formic acid-50%
acetonitrile and dried in a Speed Vac (Thermo Fisher Scientific).
Mass spectrometry
Peptides were re-dissolved in 0.5% formic acid and analyzed on an Ultimate 3000 RSLCnano System (Dionex) coupled to an LTQ FT
Ultra (Thermo Fisher Scientific) hybrid or Orbitrap Velos mass spectrometer equipped with a nanospray source. The peptides were
first loaded and desalted on a PepMap C18 trap column (0.1 mm id x 20 mm, 5mm), then separated on a PepMap 75 mm id x 25 cm
column (5mm) over a 60min linear gradient of 4 – 42%B / 90min cycle timewhen coupledwith FTUltra, or 15 cmcolumn over a 30min
linear gradient of 4 – 40% B / 60 min cycle time when coupled with Orbitrap Velos, where B is 80% CH3CN/0.1% Formic Acid. The
LTQ FT Ultra was operated in the ‘‘top 5’’ data-dependent acquisition mode with the preview mode of FT master scan enabled. The
FT full scan was set at m/z 380 – 1800 with the resolution at 100,000 at m/z 400 and AGC at 1x106 with a maximum injection time at
500 msec. The five most abundant multiply-charged precursor ions, with a minimal signal above 1000 counts, were dynamically
selected for CID fragmentation (MS/MS) in the LTQ ion trap, with the AGC set at 1x104 with the maximum injection time at
200 msec. The dynamic exclusion was set at ± 20 ppm for 45 s. For analysis on the LTQ Orbitrap Velos, the mass spectrometer
was operated in the ‘‘top 10’’ data-dependent acquisition mode with preview mode of FT master scan enabled. The Orbitrap full
scan was set at m/z 380 – 1500 with the resolution at 100,000 at m/z 400 and AGC at 1x106 with a maximum injection time at
200 msec. The 10 most abundant multiply-charged precursor ions, with a minimal signal above 2000 counts, were dynamically
selected for CID fragmentation (MS/MS) in the LTQ ion trap, with the AGC set at 5000 with the maximum injection time at
100 msec. The dynamic exclusion was set at ± 10 ppm for 60 s.
Immunofluorescence staining
Cells were fixed in 4% paraformaldehyde for 10 minutes at room temperature, blocked, and permeabilized with 3% serum in PBS
with 0.3% Triton X-100 and then incubated with the indicated antibodies at 4C overnight. After washing, cells were incubated
with Alex594-conjugated goat anti-mouse IgG (ThermoFisher, A-11032), Alex488-conjugated donkey anti-goat IgG (ThermoFisher,
A-11055) or Alex594-conjugated donkey anti-rat IgG (ThermoFisher, A-21209) and counter-stained with DAPI to detect nuclei.
Quantitative RT-PCR
Total RNA was isolated with RNeasy mini kit (QIAGEN). cDNA was synthesized with Superscript III reverse transcriptase (Invitrogen).
Real-time PCRwas performedwith TaqManGene Expression Assay (Applied Biosystems). Gene expression was determined relative
to Gapdh transcript levels. Standard deviation was calculated from PCR triplicates. Error bars give the SD of three technical qPCR
replicates from a representative experiment.
Apoptosis Assays
Dpf2fl/fl and WT ESCs were treated with ethanol or 0.65 mM of 4-Hydroxytamoxifen (4-OHT) for 96 hours, subsequently, cells
were harvested with trypsin and washed with PBS. ESCs were then stained with Annexin-APC (BD Biosciences) and 7-AAD
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(BD Biosciences) according to the manufacturer’s instructions (BD Biosciences) and analyzed by flow cytometry. Cells were gated
and analyzed for annexin V and 7-AAD. High level of annexin V and low levels of 7-aminoactinomycin D (7-AAD) show early apoptosis
in cells, whereas high levels of both annexin V and 7-AAD indicate a late stage of apoptosis. Cells were considered healthy if the levels
of both annexin V and 7-ADD were low.
Cell Cycle assay
Dpf2fl/fl and WT E14 cells were cultured in the presence or absence of 4-OHT condition for five days before the cell cycle assay was
performed. ESCs were trypsinized, re-plated and cultured in standard lif/serum ESC medium with 10uM of EdU. After incubation for
1 to 3 hours, cells were harvested for the cell cycle assay using the Click-iT@ EdU Pacific Blue flow cytometry Assay Kit (Invitrogen).
Chromatin Immunoprecipitation (ChIP) coupled with Quantitative Real-Time PCR (ChIP-qPCR)
ChIP-qPCRwas performed as previously described (Chen et al., 2013). Briefly, ChIP experiment were performed as described below
in the ChIP-seq section. After purification of the immunoprecipitated DNA, 1 mL was used per qPCR reaction. Bound regions were
detected by using paired primers given in Table S5. Real -time PCR was run using SYBR Green Mix (2x) from Applied Biosystems.
Each reaction contained 10 mL 2x SYBR Green Mix, 1 mL 10 mM Primer mix, 8 mL H2O and 1 mL immunoprecipitated DNA. The
program was used as follows: 98C 5 minutes, (98C 20 s, 60C 30 s, 72C 20 s) X 40. Quantitative PCR was performed at least
in duplicate, from at least two independent experiments, and data were normalized to input values and calculated as percent input
recovery using the DDCt method.
ChIP-seq
ChIP was typically performed inDpf2fl/fl andDpf2/ ESC lines, except for DPF2, which were done in C-FTAP tag Dpf2 knockin ESCs
and and EBs formed for 2 and 4 days respectively. Transcription factor and epigenetic regulator occupancy data generated in this
study were acquired using ChIP after crosslinking cells. Briefly, cells were grown to a final concentration of 5x107 cells for each ChIP-
seq experiment. To stabilize DPF2, BRG1, P300, EED, Oct4 and Sox2 on chromatin, cells were treated with 2 mM disuccinimidyl
glutarate (DSG) for 10 minutes prior to formaldehyde crosslinking. For all other targets (H3K4me3, H3K4me1, H3K27ac, H3K9ac,
H4tetra-ac, H3K27me3), cells were cross-linked at room temperature by the addition of formaldehyde to 1% final concentration
for 10 minutes and quenched with 0.125 M final concentration of glycine. Cross-linked cells were re-suspended in sonication buffer
(50mM HEPES-KOH pH 7.5, 140mMNaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS) and sonicated using a
Diagenode Bioruptor for three 10-minute rounds using pulsing settings (30 s ON; 1 min OFF). 10 mg of sonicated chromatin was then
incubated overnight at 4Cwith 5 mg of Flag antibody conjugated tomagnetic beads. Following the IP, beadswerewashed twice with
RIPA buffer (50mM Tris-HCl pH8, 150 mM NaCl, 2mM EDTA, 1% NP-40, 0.1% Na-deocycholate, 0.1% SDS), low salt buffer (20mM
Tris pH 8.1, 150mM NaCl, 2mM EDTA, 1% Triton X-100, 0.1% SDS), high salt buffer (20mM Tris pH 8.1, 500mM NaCl, 2mM EDTA,
1% Triton X-100, 0.1% SDS), LiCl buffer (10mM Tris pH 8.1, 250mM LiCl, 1mM EDTA, 1% Na-deoxycholate, 1% NP-40), and 1X TE.
Finally, DNA was extracted by reverse crosslinking at 60C overnight with proteinase K (20ug/mL) and 1% SDS followed by phenol:
chloroform:isoamyl alcohol purification and ethanol precipitation. All protocols for Illumina/Solexa sequencing library preparation,
sequencing, and quality control were performed as recommended by Illumina, with the minor modification of limiting the PCR ampli-
fication step to 10 cycles and sequenced using single-end 50 bp reactions on a HiSeq4000.
RNA-seq
Total RNA was purified by RNeasy Minikit (QIAGEN) according to the manufacturer’s manual. RNA concentration was determined
using Nanodrop, and 500 ng of total RNA was used for library construction using the KAPA Stranded mRNA-seq Kit. Sequencing
was performed on Illumina HiSeq 2500 machines with 125 bp pair-end mode.
Microarray analysis
Dpf2fl/fl ESCs were treated with ethanol or 4-OHT for 48 hours before the induction of EBs formation. cRNA samples for global gene
expression analyses were prepared with the linear TotalPrep RNA Amplification Kit (Ambion). Hybridizations on mouse-8 V2 chips
(Illumina) were carried out as recommended by the manufacturer.
Circularized Chromosome Conformation Capture (4C-seq)
4C experiments were performed on Dpf2fl/fl and Dpf2/ ESCs using two 4-cutter DNA restriction enzymes. The experiments were
carried out in two technical replicates, where around 10 million cells per biological sample were used. Cells were cross-linked
with 1% formaldehyde for 10 minutes followed by cell lysis and nuclei isolation. The resulting nuclei were enzymatically digested
with 1 mL/mg of fast digest MboI (Thermo Fisher Scientific) for 4.5 hours at 37C. Subsequently, thematerial was ligated with 12Weiss
units of T4DNA ligase (NewEngland Biolabs) for 4.5 hours at 16C. The ligation products were then purified using phenol-chloroform-
isoamyl alcohol followed by precipitation with ethanol. Subsequently the purified DNA was subjected to secondary digestion with
1 mL/mg of Csp6I (Thermo Fisher Scientific) for 2 hours at 37C. The digested DNA was then ligated with 12 Weiss units of T4
DNA ligase (New England Biolabs) for 4.5 hours at 16C to generate circularized chimeric DNA, which was ethanol precipitated
and cleaned using NucleoSpin gDNA Clean-Up (Macherey-Nagel) silica-membrane columns. The reading primer was designed
for a 229bp region downstream of the TSS of Tbx3 gene and the amplification was carried out using Expand Long Template PCR
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System (Roche). The sequence of the reading primer was 50-TTGCACCCGTCTTCTTGATC-30. The amplification reactions consisted
of 100ng of DNA primed with 35 picomoles of each, forward and reverse primers, and 200 mM dNTPs. 1.75 U of a Taq and Tgo
polymerase blend catalyzed the reaction. Thermal cycling was performed in GeneAmp PCR System 9700 (Applied Biosystems)
following the protocol of initial denaturation at 94C for 2 min, 29 cycles of 94C for 10 s, 55C for 1 min, 68C for 3 min, and ended
by the final elongation at 68C for 5 min. Amplification products were directly used for DNA libraries preparation for Illumina single
index, paired end sequencing using NextSeq 500 system (Illumina Inc.). The DNA libraries were prepared using KAPA HTP Library
Preparation kit for Illumina Platforms followingmanufacturer’s instructions entailing the end-repair of the amplified fragments, as well
as A-tailing and TruSeq LT (Illumina Inc.) adaptor ligation. PreparedDNA libraries were purified and subjected for sequencing. 4C-seq
was done in replicates.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics
RNA-seq andChIP-seq raw data are discrete count-based data, which follow negative binomial or Poisson distribution (Marioni et al.,
2008; Love et al., 2014), and no additional methods were used to determine whether the data met assumptions of the statistical
approach. The experiments in Figures 2C and 2D and S1A were performed once with two independent Dpf2 mutant ESC clones;
all other experiments were performed three times or more. In all Figures, n = number of biological replicates or number of clones.
All q-PCR data represent the mean of three technical replicates. All error bars represent standard deviation (SD). The Student’s
t test (unpaired, two-sided) was used to determine the significance of changes in the qPCR using Microsoft Excel. * indicates
p < 0.05, ** p < 0.01, *** < 0.001. For all other statistics tests, they were specified and performed using indicated bioinformatics
software described below in this section.
Mass spectrometry analysis
Raw files were processed with the Proteome Discover 1.4 pipeline (Thermo Fisher Scientific). Database searches were performed
with Mascot 2.5 (Matrix Science) against the mouse SwissProt database (v. January 2015). The search parameters were: trypsin/P
with a maximum of 2 missed cleavages, 10 ppm mass tolerance for MS, 0.5 Da tolerance for MS/MS, with variable modifications of
carbamidomethyl (C), N-acetylation (protein N-term), deamidation (NQ), formyl (N-term), oxidation (M), and Gln- > pyro-Glu (N-term
Q). Database search results were refined through processing withMascot Percolator. Protein identification required at least one high-
confidence peptide (FDR < 1%). External contaminants (keratins, albumin, casein, immunoglobulins and TEV protease) were
removed before further analysis. Protein lists from DPF2-FTAP experiments were compared to beta-gal-FTAP controls. High confi-
dence DPF2 interactors were identified as those solely in DPF2-FTAP experiments, or with at least 3 times more sequences in DPF2-
FTAP than in control experiments. We report these high confidence interactors identified by more than one peptide in at least one
replicate in Table S1.
Data analysis
For ChIP-seq data, reads were mapped to the mouse mm9 reference genome using bowtie version 1.1.1 (Langmead et al., 2009)
with -m 1 flag, which only allows uniquely mapped reads to be considered in the downstream analysis. Peaks were called using
Macs2 (version 2.1.0.20151222)_(Zhang et al., 2008) with–nomodel–extsize 200 -q 0.01 flags. Two biological replicates were per-
formed per experiment, and only peaks that were present in both replicates were considered. De novo Motif discovery was done
using findMotifsGenome.pl from the HOMER suite (Heinz et al., 2010) (version 4.8) on the narrowPeak files returned from Macs2.
For the analysis of peak overlap between different factors, intersectBed from the bedtools suite (Quinlan and Hall, 2010) was
used, and overlapping peaks were defined as two peaks with at least 1 bp overlap. For differential levels of H3K27ac and differential
binding byOCT4 or BRG1 inDpf2fl/fl andDpf2/ ESCs, a union peak set was created first betweenwild-type and knockout ChIP-seq
samples using mergeBed from the bedtools suite. Briefly, the narrowPeak files from wild-type and knockout ESCs were merged if
they had at least 1 bp overlap. The number of mapped reads from each condition was counted on each of the union peaks using
coverageBed from the bedtools suite. The number of reads of each union peak was normalized by the sequencing depth of different
samples. For each union peak of OCT4, BRG1 and H3K27ac, we assigned differentially bound genomic locations if at least 2-fold
difference between the wild-type and knockout samples was observed.
For RNA-seq data analysis, reads were mapped to the mouse mm9 reference genome with Tophat (Trapnell et al., 2009) version
2.0.13 and supplied with gene annotation from RefSeq. Gene expression was quantified by cuffquant, and differential gene expres-
sion test was performed using cuffdiff. Both cuffquant and cuffdiff were from the cufflinks package (Trapnell et al., 2010)
(version 2.2.1).
Microarray data analysis was done in BeadStudio and MS Excel.
GO analysis
GO analysis for enriched biological processes was performed using Metascape (http://metascape.org) to find significantly enriched
terms (P value% 0.01).
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ChromHMM ESC states, TF enrichments and data visualization
Chromatin state segmentations for the ESCs were obtained from (Chronis et al., 2017). To calculate the enrichment of binding events
in distinct chromatin states, we utilized the ChromHMM OverlapEnrichment function as previously described (Chronis et al., 2017).
The enrichment score was calculated as the ratio between observed and expected overlap between the binding event of interest and
chromatin state after accounting their relative size and the size of the mouse genome.
To produce the heatmaps in Figures 3F/H, 4C/G/I and S3D/E we aligned the given feature (such as peaks of DPF2, BRG1 or EED)
at their summit and tiled the flanking up- and downstream regions within ± 2kb in 100bp bins. For each location, we calculated
RPKM values over all 100bp bins by using the number of sequencing reads that overlapped with each bin after extension by
50bp in the direction of the alignment. To normalize to the input control, we computed at each corresponding bin a log2 input-normal-
ized RPKM value as log2(RPKMFOREGROUND) - log2(RPKMInput). For visualization in figures, each 100 bp bin was displayed with
JavaTreeview. All metaplots were produced by computing the average input-normalized RPKM value for each 100bp bin across
all locations in the given set. In Figure S4D, the fold-enrichment of Dpf2 in the vicinity (+/ 20Kb of the TSS) of up- and downregulated
genes at sites exhibiting H3K27ac, Oct4 or Brg1 binding gain or reduction was calculated with the following formulas:(%Upregulated
Dpf2 bound genes within region of interest) / (%All Dpf2 bound genes within regions of interest) and (% Downregulated Dpf2 bound
genes within region of interest)/ (%All Dpf2 bound genes within regions of interest).
TF clustering and pairwise comparisons with optimal leaf ordering
K-means clustering was employed to identify constitutive and stage specific binding of DPF2 in ESCs and EBs in Figures 5A. To
define these TF clusters, the genome was tiled into 500bp windows and the presence of TF peaks in each bin was determined.
This procedure resulted in a vector of binary data for each TF reflecting its absence or presence within 500bp windows across
the genome. The windows represented by these vectors were then clustered using R’s k-means function applying the Hartigan-
Wong method to obtain groups of windows exhibiting common combinatorial binding patterns across the genome.
In Figure 3E we applied complete linkage hierarchical clustering with optimal leaf ordering to cluster the enrichments of all pairs of
TFs (Bar-Joseph et al., 2001). The pairwise enrichments at base-pair resolution were calculated as the observed overlap divided by
the expected overlap based on the binomial background model that treats both transcription factors as independent:
EnrichmentðTFA;TFBÞ=min

100+TFAXTFB
100+ TFA  TFB=G; 500

- where the numerator is the size of the overlap between peaks of TFA and TFB and the denominator is the product between the total
number of bp occupied by peaks of TFA and TFB divided by the size of the genome (G). The maximum enrichment was set to 500. TF
datasets for TFs not generated at this study were obtained from Chronis et al., GEO: GSE90895.
Circularized Chromosome Conformation Capture (4C) analysis
Resulting data were mapped with Bowtie 2 after trimming primer sequences. Duplicates and low quality reads were discarded.
Counts for restriction enzyme fragments were generated using Bioconductor package FourCSeq (Klein et al., 2015). Only the
interactions that were supported by at least 16 read pairs (corresponding to FDR = 0.1) in both replicates were taken forward.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for ChIP-seq, RNA-seq and 4C data are E-MTAB-6165, E-MTAB-6166 and E-MTAB-6167, respectively on
ArrayExpress. The proteomics data are available via ProteomeXchange with identifier PXD011806.
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